Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

New, but not improved? Incorporating comparative-effectiveness information into FDA labeling.

Stafford RS, Wagner TH, Lavori PW.

N Engl J Med. 2009 Sep 24;361(13):1230-3. doi: 10.1056/NEJMp0906490. Epub 2009 Aug 12. No abstract available.

PMID:
19675326
[PubMed - indexed for MEDLINE]
Free Article
2.

Regulating off-label drug use--rethinking the role of the FDA.

Stafford RS.

N Engl J Med. 2008 Apr 3;358(14):1427-9. doi: 10.1056/NEJMp0802107. No abstract available.

PMID:
18385495
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

FDA mulls over paperless labeling.

Young D.

Am J Health Syst Pharm. 2007 Jun 1;64(11):1120, 1122. No abstract available.

PMID:
17519446
[PubMed - indexed for MEDLINE]
5.

FDA resurrects, finalizes labeling rule.

Traynor K.

Am J Health Syst Pharm. 2006 Mar 1;63(5):398, 400. No abstract available.

PMID:
16484509
[PubMed - indexed for MEDLINE]
6.

FDA proposes new rules that would require barcoding and new reporting procedures.

[No authors listed]

Healthc Leadersh Manag Rep. 2003 Mar;11(3):12-3. No abstract available.

PMID:
12803025
[PubMed - indexed for MEDLINE]
7.

Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Product labeling and pharmacoeconomic information.

Morris LA.

Am Heart J. 1999 May;137(5):S78-80. No abstract available.

PMID:
10220603
[PubMed - indexed for MEDLINE]
8.
9.

FDA perspectives on supplement use by patients on antithrombotic therapy.

Kim MJ.

Thromb Res. 2005;117(1-2):197-200; discussion 201-7. Epub 2005 Sep 26. No abstract available.

PMID:
16188297
[PubMed - indexed for MEDLINE]
10.

Good law from tragic facts--Congress, the FDA, and preemption.

Annas GJ.

N Engl J Med. 2009 Sep 17;361(12):1206-11. doi: 10.1056/NEJMhle0902889. No abstract available.

PMID:
19759383
[PubMed - indexed for MEDLINE]
11.

FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.

Woo JJ.

Thromb Res. 2005;117(1-2):193-6; discussion 201-7. Epub 2005 Oct 25. No abstract available.

PMID:
16253311
[PubMed - indexed for MEDLINE]
12.

Written patient information on prescription drugs. The evolution of government and voluntary programs in the United States.

Nightingale SL.

Int J Technol Assess Health Care. 1995 Summer;11(3):399-409.

PMID:
7591542
[PubMed - indexed for MEDLINE]
13.

Highlights and a hidden hazard--the FDA's new labeling regulations.

Avorn J, Shrank W.

N Engl J Med. 2006 Jun 8;354(23):2409-11. No abstract available.

PMID:
16760439
[PubMed - indexed for MEDLINE]
14.

Lost in transmission--FDA drug information that never reaches clinicians.

Schwartz LM, Woloshin S.

N Engl J Med. 2009 Oct 29;361(18):1717-20. doi: 10.1056/NEJMp0907708. Epub 2009 Oct 21. No abstract available.

PMID:
19846841
[PubMed - indexed for MEDLINE]
Free Article
15.

Recent changes to FDA-approved labeling.

[No authors listed]

Am J Health Syst Pharm. 2004 Sep 1;61(17):1766. No abstract available.

PMID:
15462244
[PubMed - indexed for MEDLINE]
16.

FDA: keynote address, PDA/FDA conference.

Chesemore RG.

J Parenter Sci Technol. 1991 Mar-Apr;45(2):71-5.

PMID:
1675676
[PubMed - indexed for MEDLINE]
17.

From the Food and Drug Administration.

Nightingale SL.

JAMA. 1999 Jan 6;281(1):27. No abstract available.

PMID:
9892435
[PubMed - indexed for MEDLINE]
18.

Deterring inefficient pharmaceutical litigation: an economic rationale for the FDA regulatory compliance defense.

Viscusi WK, Rowland SR, Dorfman HL, Walsh CJ.

Spec Law Dig Health Care Law. 1996 Mar;(205):9-52. No abstract available.

PMID:
10156421
[PubMed - indexed for MEDLINE]
19.

FDA regulatory compliance reconsidered.

Tobias C.

Cornell Law Rev. 2008 Jul;93(5):1003-38. No abstract available.

PMID:
18618969
[PubMed - indexed for MEDLINE]
20.

Regulatory issues in pediatric psychopharmacology.

Laughren TP.

J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1276-82. Review.

PMID:
8885581
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk